Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Lymphoma, B-Cell, Marginal Zone × RFB4(dsFv)-PE38 recombinant immunotoxin × Clear all

Sponsor

Interventions

Rituximab 3 fludarabine 2 Lenalidomide 2 Cyclophosphamide 2 zanubrutinib 1 venetoclax 1 umbralisib 1 ublituximab 1 tafasitamab 1 pirtobrutinib 1 axicabtagene ciloleucel 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡